Conference theme: Overcoming Today's Challenges and Driving Future Innovation

Healthcare reform in the United States has brought the issue of biopharmaceutical pricing and reimbursement to the forefront of current public discourse. This panel will evaluate the opportunities and challenges that healthcare reform represents for key stakeholders-patients, providers, payers and the biopharmaceutical industry. In particular, we will discuss the potential impact of pricing and reimbursement regulation on innovation in the biopharmaceutical industry.

Moderator
Heather Steinfield, Partner, Simon-Kucher & Partners

Panelists
Ira Klein, M.D., Chief of Staff, Office of the Chief Medical Officer, Aetna
Ted Haack, Senior Director, Head of Pricing and Reimbursement, Primary Care BU , Pfizer

In an era of decreasing venture capital spending, mounting competition, and increasingly complex regulatory environment, entrepreneurs are challenged like never before to convert great ideas into successful companies. In this panel we will discuss some of the obstacles that life sciences start-up firms are facing in today's economy and share tools and insights on how to overcome them.

Moderator
Jonathan Fleming, Managing Partner, Oxford Biosciences

Panelists
Jose-Carlos Gutierrez-Ramos, Ph.D., Senior Vice President of Research and Development, Biotherapeutics , Pfizer
Glenn Batchelder, Founder/CEO, Civitas Therapeutics
Jenna Rose, Director, Healthbox
Robert Tepper, M.D., Partner, Third Rock Ventures LLC

Healthcare IT is currently at an exciting threshold. Over the past few decades, IT has begun to streamline the process of data viewing and collection in healthcare. But now, with cloud-based and mobile solutions, advances in software and big data, and a societal shift toward connectedness, IT has the potential to revolutionize efficiency, communication, analysis, and diagnosis in healthcare. This panel will discuss the current state of healthcare IT, where it is heading, and how that will impact quality of care and the business of healthcare.

Moderator
C. William Hanson III, M.D., Chief Medical Information Officer, Vice President, University of Pennsylvania Health System

Panelists
John D. Halamka, M.D., M.S., Chief Information Officer, Beth Israel Deaconess Medical Center
Scott Andrews, Vice President of Client Development, athenahealth
Anmol Madan, Ph.D., Co-Founder, CEO, Ginger.io
Lauren Fifield, Senior Health Policy Advisor, Practice Fusion

With advances in genetic modification, nanotechnology and biochemistry, drugs today are poised for scientific breakthroughs with higher efficacy and fewer side effects. This panel will bring together experts across disciplines and functional areas to shed light on the future of drugs - their challenges and commercialization opportunities.

Moderator
Navjot Singh, Ph.D., Partner, McKinsey & Company

Panelists
Tim Harris, Ph.D., Senior Vice President of Translational Medicine and Biochemistry, Biogen Idec
Anne De Groot, M.D., CEO, Professor & Director, Epivax
Prof. Ehud Gazit, Ph.D., Chief Scientist , Science and Technology Ministry, Israel
Eric Perakslis, Ph.D., Chief Information Officer and Chief Scientist (Informatics), U.S. Food and Drug Administration